Nel ASA (OSL:NEL)
Norway · Delayed Price · Currency is NOK | Market Cap | 3.80B -24.1% |
| Revenue (ttm) | 743.64M -29.1% |
| Net Income | -1.34B |
| EPS | -0.73 |
| Shares Out | 1.84B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,148,011 |
| Open | 2.055 |
| Previous Close | 2.020 |
| Day's Range | 2.035 - 2.100 |
| 52-Week Range | 1.919 - 3.955 |
| Beta | 1.43 |
| Analysts | Sell |
| Price Target | 2.16 (+4.6%) |
| Earnings Date | Oct 15, 2026 |
About Nel ASA
Nel ASA, a hydrogen company, provides solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. It operates through Nel Alkaline Electrolyser and Nel PEM Electrolyser segments. The Nel Alkaline Electrolyser segment supplies hydrogen production equipment based on alkaline water electrolysis technology. The Nel PEM Electrolyser segment supplies hydrogen production equipment based on proton exchange membrane (PEM) water electrolysis technology. The company was formerly known as DiaGenic ASA and chang... [Read more]
Financial Performance
In 2025, Nel ASA's revenue was 963.11 million, a decrease of -30.71% compared to the previous year's 1.39 billion. Losses were -1.27 billion, 417.8% more than in 2024.
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for NEL stock is "Sell." The 12-month stock price target is kr 2.16, which is an increase of 4.60% from the latest price.
News
Nel ASA (NLLSF) Reports Q3 Revenue Plunge Amid Rising Order Backlog
Nel ASA (NLLSF) Reports Q3 Revenue Plunge Amid Rising Order Backlog
Nel ASA Earnings Call Transcript: Q3 2026
Q3 revenue fell 63% YoY as alkaline activity weakened, while PEM revenue rose 65% and orders strengthened. Quarter-end backlog was NOK 1.314 billion; a delayed HYDS project backlog is now fully classified as at-risk.
Nel ASA Slides: Q3 2026
Nel ASA has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 15, 2026.
Nel ASA Quarterly report: Q3 2026
Nel ASA has published its Q3 2026 quarterly earnings report on October 15, 2026.
Nel price target lowered to NOK 1.80 from NOK 2.90 at JPMorgan
JPMorgan lowered the firm’s price target on Nel (NLLSF) to NOK 1.80 from NOK 2.90 and keeps a Neutral rating on the shares.
Nel ASA Earnings Call Transcript: Q2 2026
Q2 2026 saw revenue decline and negative EBITDA, but order intake and backlog improved, driven by strong PEM demand and the launch of a new pressurized alkaline platform. Cash position remains solid, with no urgent funding needs, and strategic partnerships and EU funding support future growth.
Nel ASA Slides: Q2 2026
Nel ASA has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 15, 2026.
Nel ASA Quarterly report: Q2 2026
Nel ASA has published its Q2 2026 quarterly earnings report on July 15, 2026.
Nel ASA Earnings Call Transcript: Q1 2026
Q1 2026 saw lower revenues and order intake, but EBITDA improved year-over-year. The company is launching a new pressurized alkaline platform and expects order momentum to build, with a strong cash position and ongoing cost reductions supporting near-term stability.
Nel ASA Quarterly report: Q1 2026
Nel ASA has published its Q1 2026 quarterly earnings report on April 22, 2026.
Nel ASA Slides: Q1 2026
Nel ASA has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 22, 2026.
Nel price target lowered to NOK 2.30 from NOK 2.60 at Berenberg
Berenberg lowered the firm’s price target on Nel (NLLSF) to NOK 2.30 from NOK 2.60 and keeps a Hold rating on the shares.
Nel price target lowered to NOK 2.40 from NOK 2.70 at Citi
Citi lowered the firm’s price target on Nel (NLLSF) to NOK 2.40 from NOK 2.70 and keeps a Neutral rating on the shares.
Nel ASA Earnings Call Transcript: Q4 2025
Q4 2025 saw revenue growth sequentially but a year-over-year decline, with significant impairments impacting EBIT. Strong order intake and backlog, cost reductions, and a major technology launch set for 2026 position the company for improved performance, despite ongoing market and inventory challenges.
Nel ASA Annual report: Q4 2025
Nel ASA has published its Q4 2025 annual report on February 26, 2026.
Nel ASA Quarterly report: Q4 2025
Nel ASA has published its Q4 2025 quarterly earnings report on February 26, 2026.
Nel ASA Slides: Q4 2025
Nel ASA has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 26, 2026.
Nel price target raised to NOK 2.70 from NOK 2.50 at Citi
Citi raised the firm’s price target on Nel (NLLSF) to NOK 2.70 from NOK 2.50 and keeps a Neutral rating on the shares.
Nel ASA Earnings Call Transcript: Q3 2025
Q3 2025 saw a strong sequential rebound in revenue and improved EBITDA, though year-over-year results reflect a tougher market. Order backlog remains solid, with significant R&D investment and strategic partnerships advancing, while regulatory and market delays persist.
Nel ASA Quarterly report: Q3 2025
Nel ASA has published its Q3 2025 quarterly earnings report on October 29, 2025.
Nel ASA Slides: Q3 2025
Nel ASA has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 29, 2025.
Nel ASA Earnings Call Transcript: Q2 2025
Revenue fell 48% year-over-year due to lower project activity and cancellations, but cash reserves remain strong and cost reductions are taking effect. Technology development is progressing, with new products expected to improve competitiveness as the market pipeline matures.
Nel ASA Quarterly report: Q2 2025
Nel ASA has published its Q2 2025 quarterly earnings report on July 16, 2025.
Nel ASA Slides: Q2 2025
Nel ASA has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 16, 2025.
Nel ASA Earnings Call Transcript: Q1 2025
Q1 2025 saw a 69% revenue decline year-over-year, but record PEM order intake and improved margins. Cost reductions, a NOK 353 million private placement, and strong partnerships support ongoing technology investment and a healthier cash position.